nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Sun Pharma Advanced Research Company Limited (NSE India Code : SPARC) STRONG BUY

Company Name :

Enter Company Name or NSE Code

SPARC Technical Levels

Resistance 2		89.40
Resistance 1		87.50
PIVOT		85.50
Support 1		83.60
Support 2		79.70

SPARC Fundamentals

Earning Growth		-99.99%
Profit Margin		-45.95
PE		-56.43
EPS		-1.29
Quarter		30-Sep-11

SPARC Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

SPARC Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

SPARC Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

SPARC Share Price on 5-10-2012

Open		88.5
High		89
Low		84.2
Close		84.8
Volume		93201
Change		-2.85 (-3.25%)

Series		EQ
Date of Listing		18-Jul-07
Paid Up Value		1
Face Value		1
Market Capital		0 Crores
52 Week High/Low		90.45 / 64.7

Sponsored Advertisement

Sun Pharma Advanced Research Company Limited Company Profile

Sun Pharma Advanced Research Company (SUNPHADV) is a pharma research and drug discovery company. Through a scheme of arrangement, it was formed on Feb. 28, 2007 when Sun Pharmaceutical Industries demerged its innovative research and development business into the company. The company is engaged in research projects for new molecules and new delivery systems, scientists, intellectual property, space and equipment. It has projects in drug development with current lead molecules in the allergy/inflammation area. Development of chemical delivery systems for drugs that have poor absorption characteristics is another area of research. In the new chemical entity segment, the antiallergic lead molecule, SUN 1334 H, is currently in phase II clinical trials in the US with phase III trials estimated to begin in 2008. The successful pre-clinical trials of SUN-S 461, an anti-inflammatory molecule, is now ready for further stages of clinical testing. SUN-G 44, a prodrug of the currently marketed drug gabapentin, is to enter further stages of preclinical and clinical testing. SUN-B09, a muscle relaxant, is currently in preclinical studies. The novel drug delivery systems of the company has a biodegradable polymer-based product for the treatment of cancers in preclinical trials; a nanoemulsion that offers 98% encapsulation of the medication; dry powder inhalation device to be launched by 2009; ANDAs based on the wrap matrix controlled release systems filed with the USFDA; the gastro retentive innovative device Baclofen ER, which has been approved for release in India and is being filed in the US; and Tobramycin and Dexa ophthalmic solution, used in the prophylaxis of infections after cataract surgery, passing through stages of regulatory approval. The registered office of the company is located at Sun Pharma Advanced Research Centre (SPARC), Akota Road, Akota, Vadodara-390020.

SPARC Intraday Realtime Chart

SPARC Corporate Announcements

DATE	PURPOSE
31-Jul-12	Financial Result Updates
31-Jul-12	Proceedings of Annual General Meeting
02-May-12	Financial Result Updates
10-Apr-12	Press Release
01-Feb-12	Financial Result Updates

SPARC Corporate Actions

DATE	PURPOSE
23-Aug-12	RIGHTS1:7@PREM RS 66 PRSH
28-Jul-11	Annual General Meeting
28-Jul-11	Annual General Meeting

SPARC Board Meetings

MEETING DATE	PURPOSE
31-Jul-12	Un-audited Financial Results
02-May-12	Audited Financial Results
01-Feb-12	Un-audited Financial Results
24-Oct-11	Financial Results
08-Aug-11	Un-audited Financial Results

SPARC Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What is an Auction?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer